A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

Q1 2025 Management View CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase ...

In a phase 3, double-blind trial, we randomly assigned patients ... trial and their family members and caregivers, as well as the clinical research teams and support staff at the trial sites ...

Responder analysis was conducted to evaluate the percentage of patients achieving complete symptom resolution across 13 pre-specified symptom endpoints.

representing a significant clinical advantage. The efficacy appears higher than previously reported in the US Phase 3 trial 3,4 and adds to a growing body of evidence. Recent real-world data was ...

BAAR, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that it will present additional results from the Phase 3 PANOVA-3 ... or completed clinical trials exploring the ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

"On behalf of Renibus and the clinical study team ... enrollment and administration of RBT-1 in its PROTECT Phase 3 pivotal trial and announced completion of enrollment in April 2025.

Novocure (NVCR) announced that it will present additional results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields therapy for ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...